$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Boston Scientific Corporation (NYSE:BSX) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
BofA Securities Maintains Boston Scientific(BSX.US) With Buy Rating
Boston Scientific (BSX) Gets a Buy From Bank of America Securities
Internet of Medical Things (IoMT) Market Report 2024-2034, Featuring Profiles of Baxter, Bio Techne, Biotronik, Boston Scientific, Cisco Systems, GE Healthcare, IBM, Medtronic, Siemens and More
C.L. King Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $90
Catalyst Watch: Eyes on Tech With Apple, Amazon, Alphabet, and Meta Reporting
Medtronic' Affera, Sphere-9 Offering Is Threat to Boston Scientific -- Market Talk
TD Cowen Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Argus Adjusts Price Target on Boston Scientific to $105 From $90
Medtronic Gets FDA Okay for Affera Mapping and Ablation System
Express News | Morgan Stanley has raised the target stock price of Boston Scientific from $92.00 to $100.00.
NICE Recommends Boston Scientific HeartLogic Tech for Managing People With Cardiac Implants
Baird Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Promising Growth Prospects for Boston Scientific Amid Short-Term Risks and Strategic Acquisitions
Boston Scientific Price Target Maintained With a $98.00/Share by Canaccord Genuity
Boston Scientific Is Maintained at Buy by Canaccord Genuity
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $97 to $100
Daily short sale tracking: NVIDIA's short volume increased by 5 million, with a short sale ratio of 7%
NVIDIA(NVDA.US) ranked top of the list had the largest change in short volume (5.59 million shares), and the short volume ratio of The Toronto-Dominion Bank(TD.US) reached 58.85%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
Mizuho Maintains Outperform on Boston Scientific, Raises Price Target to $110